# Navdeep Tangri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/navdeep-tangri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 28,248 |
| Field | Dialysis and Renal Disease Management |
| h-index | 70 |
| i10-index | 268 |
| Last Known Institution | Seven Oaks General Hospital |
| OpenAlex ID | https://openalex.org/A5089363439 |
| ORCID iD | https://orcid.org/0000-0002-5075-6370 |
| Works | 605 |

## Researcher papers

Showing 12 of 16.

- [KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease](https://scholariq.org/papers/kdigo-2024-clinical-practice-guideline-for-the-evaluation-and-management-of/)
- [Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure](https://scholariq.org/papers/multinational-assessment-of-accuracy-of-equations-for-predicting-risk-of-kidney/)
- [The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/the-case-for-early-identification-and-intervention-of-chronic-kidney-disease/)
- [Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/heart-failure-in-chronic-kidney-disease-conclusions-from-a-kidney-disease/)
- [Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/dialysis-initiation-modality-choice-access-and-prescription-conclusions-from-a/)
- [Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns](https://scholariq.org/papers/executive-summary-of-the-kdigo-2024-clinical-practice-guideline-for-the-3/)
- [Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis](https://scholariq.org/papers/serum-potassium-and-adverse-outcomes-across-the-range-of-kidney-function-a-ckd/)
- [Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies](https://scholariq.org/papers/change-in-albuminuria-and-subsequent-risk-of-end-stage-kidney-disease-an/)
- [Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study](https://scholariq.org/papers/prevalence-outcomes-and-cost-of-chronic-kidney-disease-in-a-contemporary/)
- [A Meta-analysis of the Association of Estimated GFR, Albuminuria, Diabetes Mellitus, and Hypertension With Acute Kidney Injury](https://scholariq.org/papers/a-meta-analysis-of-the-association-of-estimated-gfr-albuminuria-diabetes/)
- [Urinary, Plasma, and Serum Biomarkers’ Utility for Predicting Acute Kidney Injury Associated With Cardiac Surgery in Adults: A Meta-analysis](https://scholariq.org/papers/urinary-plasma-and-serum-biomarkers-utility-for-predicting-acute-kidney-injury/)
- [Cystatin C as a biomarker for estimating glomerular filtration rate](https://scholariq.org/papers/cystatin-c-as-a-biomarker-for-estimating-glomerular-filtration-rate/)

## Researcher topics

- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Acute Kidney Injury Research](https://scholariq.org/topics/acute-kidney-injury-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)

## Researcher university

- [Seven Oaks General Hospital](https://scholariq.org/institutions/seven-oaks-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.